May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
FDA approval: Zenocutuzumab for NRG1+ NSCLC – IASLC
Jan 23, 2025, 16:29

FDA approval: Zenocutuzumab for NRG1+ NSCLC – IASLC

The International Association for the Study of Lung Cancer (IASLC) shared a post on X:

ICYMI, the FDA recently approved zenocutuzumab for NSCLC with an NRG1 fusion.

Catch this all-new episode of Lung Cancer Considered as Stephen V Liu and Alison Schram discuss this breakthrough and what this approval means for treating NSCLC patients with an NRG1 fusion

Listen now.”

More posts featuring IASLC.